share_log

Alliance Global Partners Downgrades Alimera Sciences to Neutral, Lowers Price Target to $4.5

Alliance Global Partners Downgrades Alimera Sciences to Neutral, Lowers Price Target to $4.5

Alliance Global Partners将Alimera Sciences的评级下调至中性,将目标价下调至4.5美元
Benzinga Real-time News ·  2022/11/21 08:32

Alliance Global Partners analyst James Molloy downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Neutral and lowers the price target from $11 to $4.5.

Alliance Global Partners分析师詹姆斯·莫洛伊将阿里梅拉科学公司(纳斯达克:ALIM)的评级从买入下调至中性,并将目标价从11美元下调至4.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发